While recent advancements in endothelial keratoplasty show that transplanting less tissue leads to faster recovery and fewer rejections, these thinner grafts are highly technically challenging for surgeons. Injecting cultured corneal endothelial cells directly into the eye emerges as the ideal alternative, promising to overcome these surgical hurdles while effectively treating primary cell failure.
USA
Japan
